Periodic Reporting for period 1 - iSTantibody (An innovative & seamless approach for the mass spectrometry analysis of monoclonal antibodies)

Summary
PreOmics GmbH is a spin-off of the Max-Planck Institute of Biochemistry founded in 2016. We are currently developing iSTantibody, a novel product for the seamless preparation of therapeutic monoclonal antibodies (mAbs) and host cell proteins (HCPs) prior to Mass Spectrometry...
More information & hyperlinks
Web resources: http://www.preomics.com